Taevas
BrazilMedical Devices
Product Registration
Market Access for Product-Registration in Brazil
Navigating the intricate global regulatory and commercial landscapes is critical for successful product launches. Our expertise ensures your life science products achieve optimal market access post-registration, maximizing their commercial potential world
Market
Global
Industry
Product-Registration
Regulator
Global Regulatory Authorities
Timeline
6-12 weeks (initial strategy)
Deliverables
Market Access Strategy, Payer Value Dossier, Reimbursement Pathways
What We Deliver
6 Pillars of Global Market Access for Product-Registration
Every engagement covers a structured set of pillars — each customised to your specific category, target segment, and strategic questions.
01
Global Regulatory Intelligence & Strategy
We provide in-depth analysis of global regulatory requirements and evolving policies, ensuring your product registration strategy aligns with future market access demands across diverse jurisdictions.
Horizon Scanning for Regulatory Changes
Strategic Roadmapping for Multi-Country Submissions
How It Works
How We Ensure Global Market Access Success
A structured engagement — typically delivered in a few weeks.
Step 1 · Week 1-2
Discovery & Landscape Analysis
We initiate with a comprehensive review of your product, clinical data, and target markets. This includes an in-depth analysis of the global regulatory, payer, and competitive landscapes.
Market Snapshot
Market Overview: Global + Product-Registration
Increasing Regulatory Complexity
The global regulatory environment is continuously evolving, with divergent requirements and accelerated pathways adding layers of complexity to product registration and subsequent market access.
Payer Scrutiny & Value Demands
Payers globally are demanding more robust evidence of clinical and economic value, making integrated market access strategies essential from early development stages to secure reimbursement.
Harmonization Challenges
While efforts toward regulatory harmonization exist, significant regional differences persist in HTA processes, pricing policies, and stakeholder expectations, necessitating highly localized strategies.
What's Included
Deliverables
A structured, decision-ready package of deliverables.
Global Market Access Strategy Report
A comprehensive document outlining the recommended strategy for achieving optimal market access across target geographies, post-registration.
Payer Value Dossier & Communication Toolkit
Customized dossiers and communication materials designed to articulate your product's value proposition to diverse payer audiences globally.
Pricing & Reimbursement Pathway Roadmap
Detailed guidance on optimal pricing strategies, potential reimbursement pathways, and HTA submission requirements for key markets.
Competitive Landscape & Gap Analysis
An analysis identifying market opportunities, competitive threats, and strategic gaps in the global market access landscape.
Who This Is For
Use Cases
Market Entry
Launching a Novel Biologic in Multiple Regions
A client developed a groundbreaking biologic and needed to ensure rapid, favorable market access across North America, Europe, and Asia post-FDA/EMA approval, despite varying HTA requirements and pricing pressures.
Outcome
Taevas Life Sciences developed a harmonized global strategy, leading to successful reimbursement in 10+ countries within 18 months.
Next Steps
Related Services
FAQ
Frequently Asked Questions
Get Started
Ready to Secure Optimal Market Access for Your Global Product?
Partner with Taevas Life Sciences to transform your product registration into a commercial success story worldwide. Our expert strategies will unlock your product's full potential.
Navigate Complex Global Landscapes
Maximize Commercial Potential
Ensure Patient Access
Mitigate Market Entry Risks